Splenic macrophages as the source of bacteraemia during pneumococcal pneumonia-Reference-Cited by-同舟云学术

Splenic macrophages as the source of bacteraemia during pneumococcal pneumonia

Published:2021-10 Issue: Volume:72 Page:103601
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Carreno David,Wanford Joseph J,Jasiunaite Zydrune,Hames Ryan G.,Chung Wen Y^ORCID,Dennison Ashley R.,Straatman Kornelis,Martinez-Pomares Luisa,Pareek Manish,Orihuela Carlos J.^ORCID,Restrepo Marcos I.,Lim Wei Shen,Andrew Peter W.,Moxon E. Richard,Oggioni Marco R^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference49 articles.

1. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015;Wang;Lancet,2016

2. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016;Troeger;Lancet Infect Dis,2018

3. British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together;Lim;Thorax,2015

4. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study;Lim;Thorax,2003

5. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America;Metlay;Am J Respir Crit Care Med,2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extra-pulmonary control of respiratory defense;Cellular Immunology;2024-07

2. Impaired upper respiratory tract barrier function during postnatal development predisposes to invasive pneumococcal disease;PLOS Pathogens;2024-05-08

3. Synthetic mRNA delivered to human cells leads to expression of Cpl-1 bacteriophage-endolysin with activity against Streptococcus pneumoniae;Molecular Therapy - Nucleic Acids;2024-03

4. The microbiota–gut–brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets;The FEBS Journal;2024-03

5. Immunomodulation of susceptibility to pneumococcal pneumonia infection in mouse lungs exposed to carbon nanoparticles via dysregulation of innate and adaptive immune responses;Toxicology and Applied Pharmacology;2024-02